DOCSLIB.ORG

Aerospace Medicine and Biology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

AEROSPACE MEDICINE AND BIOLOGY A CONTINUING BIBLIOGRAPHY GPO PRICE S f OTS PRICE(S) S / Hard copy (HC) Microfiche (M F) lo. 95 NASA SP-7011 (08) AEROSPACE MEDICINE AND BIOLOGY A CONTINUING BIBLIOGRAPHY A selection of annotated references to unclas- sified reports and journal articles that were introduced into the NASA Information System during January, 1965. Scientific and Technical Information Division NATIONAL AERONAUTICS AND SPACE ADMlNlSTRATlON WASHINGTON, D.C. FEBRUARY 1965 I . INTRODUCTION SP-7011 (08) is the eighth issue of Aerospace Medicine and Biology, NASA’s continuing bibliography for the abstracting and announcement of current references on this subject. The publication is compiled through the cooperative efforts of the Aerospace Medicine and Biology Bibliography Project (AM BBP) of the Library of Congress (LC), the American Institute of Aeronautics and Astronautics, and NASA. It assembles, within the covers of a single bibliographic announcement, groups of references that were formerly announced in separate journals and provides a convenient compilation for medical and biological sci- entists. Additional background details for this publication can be found in the first issue, SP-70 I I. In its subject coverage, Aerospace Medicine and Biology concentrates on the biological, physiological, psychological, and environmental effects to which man is subjected during and following simulated or actual flight in the earth’s atmosphere or in interplanetary space. References describing similar effects on biological organisms of lower order are also in- cluded. Such related topics as sanitary problems, phar macology. toxicology, safety and survival, life support systems, exobiology, and personnel factors receive appropriate atten- tion. In general, emphasis will be placed on applied research, but references to fundamental studies and theoretical principles related to experimental development also qualify for inclusion. The contents of this issue are comprised of abstracts that were prepared by the three contributing organizations. Each entry in SP-7011 (08) consists of a standard citation accompanied by its abstract. It is included in one of three groups of references that appear in the following order: a. NASA entries identified by their STAR accession numbers (N65-10000 series), b. AlAA entries identified by their IAA accession numbers (A65-10000 series); and c. LC entries identified by a number in the A65-80000 series. Many of the abstracts included in this publication have been reproduced from those appearing in STAR and IAA. This procedure. adopted in the interests of economy and speed, has introduced some variation in size, style, and intensity of type. I AVAILABILITY OF DOCUMENTS STAR Entries NASA documents listed are available without charge to: 1. NASA Offices, Centers, contractors, subcontractors, grantees, and consultants. 2. Other U. S. Government agencies and their contractors. 3. Libraries that maintain depositories of NASA documents for public reference. 4. Other organizations having a need for NASA documents in work related to the aerospace program. 5. Foreign organizations that exchange publications with NASA or that maintain depositories of NASA documents for public use. Non-NASA documents listed are provided by NASA without charge only to NASA Offices, Centers, contractors, subcontractors, grantees, and consultants. Organizations and individuals not falling into one of these categories may purchase the documents listed from either of two sales agencies, as specifically identified in the abstrqct section: Clearinghouse for Federal Scientific Superintendent of Documents (GPO) and Technical Information (OTS), U.S. Government Printing Office Port Royal Road, Springfield, Virginia, 22 15 1 Washington, ,D.C. 20402 Information on the availability of this publication and other reports covering NASA scientific and technical information may be obtained by writing to: Scientific and Technical Information Division National Aeronautics and Space Administration Code ATSS-AD Washington, D.C. 20546 Collections of NASA documents are currently on file in the organizations listed on the inside ofthe back cover. (continued) I c IAA Entries All articles listed are available from the American lnstitute of Aeronautics and Astro- nautics, Technical Information Service. Individual and Corporate AIAA Members in the United States and Canada may borrow publications without charge. Interlibrary loan privileges are extended to the libraries of government agencies and of academic non- profit institutions in the United States and Canada. Loan requests may be made by mail, telephone, telegram, or in person. Additional information about lending, photocopying, and reference service will be furnished on request. Address all inquiries to: Technical Information Service American Institute of Aeronautics and Astronautics, Inc. 750 Third Avenue, New Y ork 17, New Y ork For further details please consult the Introductions to STAR and IAA, respectively. LC Entries Articles listed are available in the journals in which they appeared. They may be borrowed or consulted in libraries maintaining sets of these journals. In some instances, reprints may be available from the journal offices. AVAILABILITY OF THIS BIBLIOGRAPHY Copies of Aerospace Medicine and Biology (SP-7011) and its supplements can be obtained from NASA (Code ATAA-A), without charge, by NASA offices and contractors, U .S. Government agencies and their contractors, and organizations that are working in direct support of NASA programs. Other organizations can purchase copies of the bibliography from the Offce of Technical Services, U .S. Department of Commerce. ... 111 TABLE OF CONTENTS Page STAR Entries (N65.10000) ................................. 1 IAA Entries (A65-10000) .................................. 25 LC Entries (A65-80000) .................................. 35 Subject Index .......................................... 1-1 Corporate Source Index ................................... 1-31 Personal Author Index .................................... 1-35 iv effects were exhibited Eight other cleansing agents had seri- ous disadvantages due to slow biodegradability or extreme foaming. or both The relationship between biodegradability and chemical structure of the nonionic and anionic synthetic detergents is discussed Human stomach content of nonpatho- STAR ENTRIES logic origin was found to be rapidly metabolized. and pH depression that results from the discharge of vomitus through a waste treatment system had only slight observable metabolic effect through pH 4 The disposal of selected cleansing agents. vomitus. and pH depressant substances posed no apparent N65-10012# University Coll , Cork (Ireland) problems Author STUDIES OF THE PROPERTIES AND STRUCTURE OF PURIFIED MAMMALIAN ADENOSINE DEAMINASE ISOLATED FROM CALF INTESTINE Third Annual Tech- nical Status Report, 1 Jul. 1963-1 Jul. 1964 N65-10034# Joint Publications Research Service. Washing- ThomasG Brady (19641 26p refs ton. D C (Contract DA-91-591-EUC-2901) STUDIES OF INDUSTRIAL TOXICOLOGY (AD-444390) 9 Nov 1964 34 p refs Transl into ENGLISH from Gigiena Truda I Prof Zabolevaniya (Moscow). v 8, no 9, Sep 1964 Various modifications of the purification procedure have p 3-10, 25-28.42-45.62-63 been investigated in an effort to eliminate bacterial contamina- (JPRS-27282. TT-64-51538) OTS $2 00 tion, reduce inactivation. and give stable concentrates By means of Sephadex columns it has been found that purified CONTENTS preparations of adenosine deaminase usually contain a quan- 1 VANADIUM SMELTING IN THE LIGHT OF INDUS- tity of inactive material of approximately twice the molecular TRIAL HYGIENE AND PROBLEMS PERTAINING TO THE weight of the active enzyme Treatment of the enzyme with PREVENTION OF OCCUPATIONAL DISEASES AND POI- 2-mercapto-ethanol converts it into lower molecular enzym- SONING I V Roshchin pl-11 refs ically active fragments Bovine lung and spleen have high 2 PROVISIONAL METHODICAL INSTRUCTIONS FOR deaminase activity High activity is uniformly distributed in cat ORGANIZING EXPERIMENTAL INVESTIGATIONS TO ES- lung Dog bone marrow is low active The levels of deaminase TABLISH MAXIMUM PERMISSIBLE CONCENTRATIONS found in some tissues of rat. rabbit. and cat were compared OF TOXIC SUBSTANCES IN THE AIR OF INDUSTRIAL with previously published data Considerable agreement has PREMISES p 12-19 been found The pH optima and isoelectric points of the de- 3 DATA ON THE BERYLLIUM LEVEL IN BIOLOGICAL aminases isolated from different species have been compared MEDIA IN THE PRESENCE OF BERYLLIOSIS P A RO- Further investigations on the separation of the isozymes of zenberg and A A Orlova p 20-26 refs calf mucosa are described By using the zymogram technique. 4 LENINGRAD SYMPOSIUM ON PROBLEMS OF GEN- it has been possible to show that mouse duodenum contains ERAL INDUSTRIAL TOXICOLOGY Ye T Lykhina and N A three isozymes Author Minkina D 27-31 N65-10014# Boeing Co . Seattle. Wash EFFECTS OF MISCELLANEOUS WASTES ON MESO- PHILIC ACTIVATED SLUDGE: SOAPS, DETERGENTS, AND VOMITUS N65-1W35# Joint Publications Research Service. Washing- R W Okey. R L Cohen. and D D Chapman Brooks AF8 ton. D C Tex . School of Aerospace Med Aug 1964 13 p refs SIMULATED SPACE FLIGHT EXPERIMENTS (Contract AF 41(657)-387) 9 Nov 1964 12 p Transl into ENGLISH from Med Gazeta (SAM-TDR-64 41 AD-449425) (Moscow) no 75. 18 Sep 1964 p 3. no 80. 6 Oct 1964 Effects of soap synthetic detergents. and vomitus on the (JPRS-27286. TT-64-51542) OTS $1 00 performance of high solids. mesophilic-activated-sludge.
Recommended publications
  • Pharmacology

    Pharmacology

    Pharmacology New for 2020-2021 Competitor orientation deleted from ILC. Event Summary Pharmacology provides HOSA members with the opportunity to gain knowledge and skills regarding the area of healthcare concerned with uses, effects, and modes of actions of drugs. This competitive event consists of a written test with a tie-breaker essay question. This event aims to inspire members to learn about how drugs work in the body, proper administration, and adaptations for different patients and conditions. Dress Code Competitors must be in official HOSA uniform or proper business attire. Bonus points will be awarded for proper dress. General Rules 1. Competitors in this event must be active members of HOSA-Future Health Professionals, in good standing. 2. Secondary and Postsecondary/Collegiate divisions are eligible to compete in this event. 3. Competitors must be familiar with and adhere to the “General Rules and Regulations of the HOSA Competitive Events Program (GRR)." 4. All competitors shall report to the site of the event at the time designated for each round of competition. At ILC, competitor’s photo ID must be presented prior to ALL competition rounds. Official References • Fulcher, Soto and Fulcher. Pharmacology: Principles and Applications. Elsevier, Latest edition. • Ford, Susan and Sally Roach. Roach’s Introductory Clinical Pharmacology. Wolters Kluwer, Latest edition. Written Test 5. Test Instructions: The written test will consist of 100 multiple choice items in a maximum of 90 minutes. 6. Time Remaining Announcements: There will be a verbal announcement when there are 60 minutes, 30 minutes, 15 minutes, 5 minutes, and 1 minute remaining to complete the test.
  • Cell Biology and Fundamentals in Histology - En-Cours-2018-Liepr1004 Liepr1004 Cell Biology and Fundamentals in 2018 Histology

    Cell Biology and Fundamentals in Histology - En-Cours-2018-Liepr1004 Liepr1004 Cell Biology and Fundamentals in 2018 Histology

    Université catholique de Louvain - Cell biology and fundamentals in histology - en-cours-2018-liepr1004 liepr1004 Cell biology and fundamentals in 2018 histology 5 credits 45.0 h Q2 Teacher(s) Behets Wydemans Catherine ;Henriet Patrick ; Language : French Place of the course Louvain-la-Neuve Main themes The major themes are : - Characteristics common to all living species - The human cell, its functioning and division - Classical, evolutive and molecular genetics - Cellular bases in sexual reproduction - The differents cell types and their organisation in tissues - The major steps in human embryonic development Aims By the end of the module, students should understand the bases of unicity and diversity in the living world. They will know the structure and functioning of human cell and genome as well as the mechanisms of 1 cell division and embryonic development. Moreover, they will know the structure of the major types of human tissues. - - - - The contribution of this Teaching Unit to the development and command of the skills and learning outcomes of the programme(s) can be accessed at the end of this sheet, in the section entitled “Programmes/courses offering this Teaching Unit”. Content (auteurs - titulaires actuels) : P. Henriet and Ph. van den Bosch de Aguilar 1. UNICITY IN THE LIVING WORLD 2. THE HUMAN CELL 3. DIVERSITY IN THE LIVING WORLD 4. MOLECULAR GENETICS 5. CELL DIVISION 6. GAMETOGENESIS AND FERTILIZATION 7. INTRODUCTION TO HUMAN EMBRYOLOGY Histology 1. EPITHELIAL TISSUE 2. CONNECTIVE TISSUE 3. BLOOD TISSUE 4. MUSCLE TISSUE
  • Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development

    Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development

    Clinical Pharmacology 1: Phase 1 Studies and Early Drug Development Gerlie Gieser, Ph.D. Office of Clinical Pharmacology, Div. IV Objectives • Outline the Phase 1 studies conducted to characterize the Clinical Pharmacology of a drug; describe important design elements of and the information gained from these studies. • List the Clinical Pharmacology characteristics of an Ideal Drug • Describe how the Clinical Pharmacology information from Phase 1 can help design Phase 2/3 trials • Discuss the timing of Clinical Pharmacology studies during drug development, and provide examples of how the information generated could impact the overall clinical development plan and product labeling. Phase 1 of Drug Development CLINICAL DEVELOPMENT RESEARCH PRE POST AND CLINICAL APPROVAL 1 DISCOVERY DEVELOPMENT 2 3 PHASE e e e s s s a a a h h h P P P Clinical Pharmacology Studies Initial IND (first in human) NDA/BLA SUBMISSION Phase 1 – studies designed mainly to investigate the safety/tolerability (if possible, identify MTD), pharmacokinetics and pharmacodynamics of an investigational drug in humans Clinical Pharmacology • Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of the drug in humans – PK: what the body does to the drug (Absorption, Distribution, Metabolism, Excretion) – PD: what the drug does to the body • PK and PD profiles of the drug are influenced by physicochemical properties of the drug, product/formulation, administration route, patient’s intrinsic and extrinsic factors (e.g., organ dysfunction, diseases, concomitant medications,
  • I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St

    I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St

    2014;22(1):13-18 TCP Translational and Clinical Pharmacology http://dx.doi.org/10.12793/tcp.2014.22.1.13 Clinical Pharmacology Review for Primary Health Care Providers: I. Antihistamines Seunghoon Han* Department of Clinical Pharmacology and Therapeutics, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 137-701, Korea *Correspondence: S. Han; Tel: +82-2-2258-7326, Fax: +82-2-2258-7876, E-mail: [email protected] Received 31 May 2014 Primary health care providers play a critical role in maintaining public health, and the appropri- Accepted 31 May 2014 ate use of pharmaceutical products is one of the major parts of their practice. This series of articles, pISSN: 2289-0882 entitled ‘Clinical Pharmacology Review for Primary Health Care Providers,’ is intended to help pri- mary health care providers select more appropriate prescriptions for frequently used drugs based on up-to-date information. We expect that this effort will contribute to improvements in public health and diminish unnecessary drug use. Introduction tion on the H1 receptor.[8] THERAPEU Antihistamines include some of the most frequently prescribed drugs in the primary health care environment for the symp- Generations and Classes tomatic relief of allergic diseases, the common cold, urticaria, Many primary health care providers are well-informed about T and insomnia.[1-5] The importance of antihistamines has been the different ‘generations’ of antihistamines but not about the ICS TU emphasized as the prevalence of target diseases increases.[6,7] different ‘classes’ characterized according to chemical structure. However, the appropriate use, clinical effectiveness, and target [1] This discrepancy seems reasonable because ‘inter-generation’ T populations for prescription of antihistamines are still a matter differences are more prominent than ‘inter-class’ differences.
  • Guidance for Reviewers Pharmacology/Toxicology Review Format

    Guidance for Reviewers Pharmacology/Toxicology Review Format

    Guidance for Reviewers Pharmacology/Toxicology Review Format U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Pharmacology/Toxicology May 2001 Guidance for Reviewers Pharmacology/Toxicology Review Format Additional copies are available from: Drug Information Branch (HFD-210) Center for Drug Evaluation and Research (CDER) 5600 Fishers Lane, Rockville, MD 20857, (Tel) 301-827-4570 Internet at http://www.fda.gov/der/guidance/index.htm U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Pharmacology/Toxicology May 2001 Guidance for Reviewers Table of Contents I. INTRODUCTION ....................................................................................................1 II. BACKGROUND.......................................................................................................1 III. DISCUSSION ...........................................................................................................1 A. IND REVIEW FORMAT ....................................................................................1 B. NDA REVIEW FORMAT...................................................................................1 IV. ATTACHMENTS .....................................................................................................1 A. IND REVIEW FORMAT ....................................................................................A-i B. NDA REVIEW FORMAT...................................................................................B-i
  • Department of Pharmacology (GRAD) 1

    Department of Pharmacology (GRAD) 1

    Department of Pharmacology (GRAD) 1 faculty participate fully at all levels. The department has the highest DEPARTMENT OF level of NIH funding of all pharmacology departments and a great diversity of research areas is available to trainees. These areas PHARMACOLOGY (GRAD) include cell surface receptors, G proteins, protein kinases, and signal transduction mechanisms; neuropharmacology; nucleic acids, cancer, Contact Information and antimicrobial pharmacology; and experimental therapeutics. Cell and molecular approaches are particularly strong, but systems-level research Department of Pharmacology such as behavioral pharmacology and analysis of knock-in and knock-out Visit Program Website (http://www.med.unc.edu/pharm/) mice is also well-represented. Excellent physical facilities are available for all research areas. Henrik Dohlman, Chair Students completing the training program will have acquired basic The Department of Pharmacology offers a program of study that leads knowledge of pharmacology and related fields, in-depth knowledge in to the degree of doctor of philosophy in pharmacology. The curriculum is their dissertation research area, the ability to evaluate scientific literature, individualized in recognition of the diverse backgrounds and interests of mastery of a variety of laboratory procedures, skill in planning and students and the broad scope of the discipline of pharmacology. executing an important research project in pharmacology, and the ability The department offers a variety of research areas including to communicate results, analysis, and interpretation. These skills provide a sound basis for successful scientific careers in academia, government, 1. Receptors and signal transduction or industry. 2. Ion channels To apply to BBSP, students must use The Graduate School's online 3.
  • Immune Response and Histology of Humoral Rejection in Kidney

    Immune Response and Histology of Humoral Rejection in Kidney

    Document downloaded from http://www.elsevier.es, day 23/05/2017. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. n e f r o l o g i a 2 0 1 6;3 6(4):354–367 Revista de la Sociedad Española de Nefrología www.revistanefrologia.com Review Immune response and histology of humoral rejection in kidney transplantation a,∗ a b a Miguel González-Molina , Pedro Ruiz-Esteban , Abelardo Caballero , Dolores Burgos , a c a a Mercedes Cabello , Miriam Leon , Laura Fuentes , Domingo Hernandez a Nephrology Department, Regional University Hospital of Malaga, Malaga University, IBIMA, REDINREN RD12/0021/0015, Malaga, Spain b Immunology Department, Regional University Hospital of Malaga, Malaga University, IBIMA, REDINREN RD12/0021/0015, Malaga, Spain c Pathology Department, Regional University Hospital of Malaga, Malaga University, IBIMA, REDINREN RD12/0021/0015, Malaga, Spain a r t i c l e i n f o a b s t r a c t Article history: The adaptive immune response forms the basis of allograft rejection. Its weapons are direct Received 4 June 2015 cellular cytotoxicity, identified from the beginning of organ transplantation, and/or anti- Accepted 26 March 2016 bodies, limited to hyperacute rejection by preformed antibodies and not as an allogenic Available online 3 June 2016 response. This resulted in allogenic response being thought for decades to have just a cellu- lar origin. But the experimental studies by Gorer demonstrating tissue damage in allografts Keywords: due to antibodies secreted by B lymphocytes activated against polymorphic molecules were Immune response disregarded.
  • Satellitosis, a Crosstalk Between Neurons, Vascular Structures and Neoplastic Cells in Brain Tumours; Early Manifestation of Invasive Behaviour

    Satellitosis, a Crosstalk Between Neurons, Vascular Structures and Neoplastic Cells in Brain Tumours; Early Manifestation of Invasive Behaviour

    cancers Review Satellitosis, a Crosstalk between Neurons, Vascular Structures and Neoplastic Cells in Brain Tumours; Early Manifestation of Invasive Behaviour Prospero Civita 1,2,* , Ortenzi Valerio 3 , Antonio Giuseppe Naccarato 3 , Mark Gumbleton 2 and Geoffrey J. Pilkington 1,2,4,* 1 Brain Tumour Research Centre, Institute of Biological and Biomedical Sciences (IBBS), School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK 2 School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff CF10 3NB, UK; gumbleton@cardiff.ac.uk 3 Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, 56100 Pisa, Italy; [email protected] (O.V.); [email protected] (A.G.N.) 4 Division of Neuroscience, Department of Basic and Clinical Neuroscience, Institute of Psychiatry & Neurology, King’s College London, London SE5 9RX, UK * Correspondence: CivitaP@cardiff.ac.uk (P.C.); geoff[email protected] (G.J.P.) Received: 9 November 2020; Accepted: 4 December 2020; Published: 11 December 2020 Simple Summary: This article reviews the concept of cellular satellitosis as originally described histologically by Santiago Ramón y Cajal in 1899 and Hans Joachim Scherer, more specifically in the context of glioblastoma invasiveness, during the early part of the 20th century. With the advent of new and emerging molecular technologies in the 21st century, the significance of both vascular and neuronal satellitosis by neoplastic cells offers intriguing possibilities into further clarifying the development, pathobiology and therapy of malignant glioma through closer investigation into the nature of these histological hallmarks.
  • Basic Histology (23 Questions): Oral Histology (16 Questions

    Basic Histology (23 Questions): Oral Histology (16 Questions

    Board Question Breakdown (Anatomic Sciences section) The Anatomic Sciences portion of part I of the Dental Board exams consists of 100 test items. They are broken up into the following distribution: Gross Anatomy (50 questions): Head - 28 questions broken down in this fashion: - Oral cavity - 6 questions - Extraoral structures - 12 questions - Osteology - 6 questions - TMJ and muscles of mastication - 4 questions Neck - 5 questions Upper Limb - 3 questions Thoracic cavity - 5 questions Abdominopelvic cavity - 2 questions Neuroanatomy (CNS, ANS +) - 7 questions Basic Histology (23 questions): Ultrastructure (cell organelles) - 4 questions Basic tissues - 4 questions Bone, cartilage & joints - 3 questions Lymphatic & circulatory systems - 3 questions Endocrine system - 2 questions Respiratory system - 1 question Gastrointestinal system - 3 questions Genitouirinary systems - (reproductive & urinary) 2 questions Integument - 1 question Oral Histology (16 questions): Tooth & supporting structures - 9 questions Soft oral tissues (including dentin) - 5 questions Temporomandibular joint - 2 questions Developmental Biology (11 questions): Osteogenesis (bone formation) - 2 questions Tooth development, eruption & movement - 4 questions General embryology - 2 questions 2 National Board Part 1: Review questions for histology/oral histology (Answers follow at the end) 1. Normally most of the circulating white blood cells are a. basophilic leukocytes b. monocytes c. lymphocytes d. eosinophilic leukocytes e. neutrophilic leukocytes 2. Blood platelets are products of a. osteoclasts b. basophils c. red blood cells d. plasma cells e. megakaryocytes 3. Bacteria are frequently ingested by a. neutrophilic leukocytes b. basophilic leukocytes c. mast cells d. small lymphocytes e. fibrocytes 4. It is believed that worn out red cells are normally destroyed in the spleen by a. neutrophils b.
  • The Histology of the Neuromuscular Junction In

    The Histology of the Neuromuscular Junction In

    75 THE HISTOLOGY OF THE NEUROMUSCULAR JUNCTION Downloaded from https://academic.oup.com/brain/article/84/1/75/372729 by guest on 27 September 2021 IN DYSTROPHIA MYOTONICA BY VIOLET MACDERMOT Department of Neurology, St. Thomas' Hospital, London, S.E.I (1) INTRODUCTION DYSTROPJHC MYOTONICA is a familial disease affecting males and females, usually presenting in adult life, characterized by muscular wasting and weakness together with certain other features. The muscles mainly in- volved are the temporal, masseter, facial, sternomastoid and limb muscles, in the latter those mainly affected being peripheral in distribution. A widespread disorder of muscular contraction, myotonia, is also present but is noticed chiefly in the tongue and in the muscles involved in grasping. The other features of the condition are some degree of mental defect, dysphonia, cataracts, frontal baldness, sparse body hair and testicular atrophy. Any of the manifestations of the disease may be absent and the order of presentation of symptoms is variable. The myotonia may precede muscular wasting by many years or may occur independently. In those muscles which are severely wasted the myotonia tends to disappear. The interest of dystrophia myotonica lies in the peculiar distribution of muscle involvement and in the combination of a disorder of muscle function with endocrine and other dysplasic features. The results of histological examination of biopsy and post-mortem material have been described and reviewed by numerous workers, notably Steinert (1909), Adie and Greenfield (1923), Keschner and Davison (1933), Hassin and Kesert (1948), Wohlfart (1951), Adams, Denny-Brown and Pearson (1953), Greenfield, Shy, Alvord and Berg (1957).
  • Pharmacology 101

    Pharmacology 101

    Pharmacology 101 Tyler Fischback, PharmD, BCPS, DPLA Clinical Pharmacy Manager Confluence Health Wenatchee, WA Objectives • Define Pharmacology, Pharmacokinetics and Pharmacodynamics • Understand how drug interactions work • Understand how some specific drugs behave in the body (opioids, benzodiazepines, amiodarone) • Apply pharmacology principles into practice Medication Errors and Adverse Drug Events • Error: An error of commission or omission at any step along the pathway that begins when a clinician prescribes a medication and ends when the patient actually received the medication. • ADE: Harm experienced by a patient as a result of exposure to a medication. ADE does not necessarily indicate an error or poor care. However, ~1/2 of ADEs are preventable. Anyone here ever seen a medication error or adverse drug event? Anyone here ever made a medication error? How many different prescription medications are available on the U.S. market? 1,000 So, it’s no surprise why we see so many problems………………… EXCEPT……. The real number is 10,000 Adverse Drug Events • ~1/3 of U.S. adults use 5 or more medications • Annually, ADE = 700,000 ER visits and 100,000 hospitalizations • So, is pharmacology important to your work? • Additionally, 5% of hospitalized patient experience an ADE during their stay • High risk: Anticoagulants, Opioids, Insulin, Cardiac, and Transitions of Care Adverse Drug Events, cont. • Elderly are more susceptible • Pediatrics patients more susceptible (weight-based dosing), especially liquids • Caregivers and patients admittedly
  • Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations

    Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations

    International Journal of Molecular Sciences Editorial Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations Giuliano Ciarimboli Experimental Nephrology, Department of Internal Medicine D, University Hospital Münster, 48149 Münster, Germany; [email protected] This editorial summarizes the 13 scientific papers published in the Special Issue “Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations” of the International Journal of Molecular Sciences. In this Special Issue, the readers will find integrative information on transporters for organic cations. Besides reviews on physi- ology, pharmacology, and toxicology of these transporters [1–3], which offer a concise overview of the field, the readers will find original research work focusing on specific transporter aspects. Specifically, the review “Organic Cation Transporters in Human Physiology, Phar- macology, and Toxicology” by Samodelov et al. [1] summarizes well the general as- pects of physiology, pharmacology, and toxicology of transporter for organic cations. The other review “Organic Cation Transporters in the Lung—Current and Emerging (Patho)Physiological and Pharmacological Concepts” by Ali Selo et al. [2] focuses on these aspects of transporters for organic cations in the lung, an important but often ne- glected field. In the paper “Systems Biology Analysis Reveals Eight SLC22 Transporter Subgroups, Including OATs, OCTs, and OCTNs”, by performing a system biology analysis of SLC22 transporters, Engelhart et al. [4] suggest the existence of a transporter–metabolite network. They propose that, in this network, mono-, oligo-, and multi-specific SLC22 transporters Citation: Ciarimboli, G. Physiology, interact to regulate concentrations and fluxes of many metabolites and signaling molecules. Biochemistry, and Pharmacology of In particular, the organic cation transporters (OCT) subgroup seems to be associated with Transporters for Organic Cations.